Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Automated macular pathology diagnosis in three-dimensional (3D) spectral domain optical coherence tomography (SD-OCT) images
Multilayer films having reduced curling
Developing device
Lateral flow test kit and method for detecting an analyte
System and method for updating firmware
Minimizing mismatch during compensation
Tap and linking module TDO register, gating for TCK and TMS
  Randomly Featured Patents
Image sensing device with reduced smear
Cold spray mass spectrometric device
System and method for interfacing a privacy management service with a voice mail system
Clutch assembly for planetary-gear trains
Method of supplying nutrients to plants
Preemptive multi-tasking with cooperative groups of tasks
Method of treating cancer tumors with imine porphyrin compounds
Measuring apparatus for measuring flow rate of a fluid
Integrated system for forming sheets and films of synthetic resins
Disposable food container